For instance, genetic Hif1α ablation in myeloid cells protects against the development of HFD-induced metabolic inflammation and insulin resistance [57–59], while macrophage HIF2α suppresses inflammation and alleviates obesity-related insulin resistance [60, 61]. Here, EPAS1 is linked to obesity due to melanocortin 4 receptor deficiency.